1 Market Overview

• 1.1 Product Overview and Scope
• 1.2 Market Estimation Caveats and Base Year
• 1.3 Market Analysis by Type
  • 1.3.1 Overview: Global Pet Vaccine Consumption Value by Type: 2020 Versus 2024 Versus 2031
  • 1.3.2 Nasal Administration
  • 1.3.3 Injection
  • 1.3.4 Other
• 1.4 Market Analysis by Application
  • 1.4.1 Overview: Global Pet Vaccine Consumption Value by Application: 2020 Versus 2024 Versus 2031
  • 1.4.2 Cat
  • 1.4.3 Dog
  • 1.4.4 Other
• 1.5 Global Pet Vaccine Market Size & Forecast
  • 1.5.1 Global Pet Vaccine Consumption Value (2020 & 2024 & 2031)
  • 1.5.2 Global Pet Vaccine Sales Quantity (2020-2031)
  • 1.5.3 Global Pet Vaccine Average Price (2020-2031)

2 Manufacturers Profiles

• 2.1 Boehringer Ingelheim
  • 2.1.1 Boehringer Ingelheim Details
  • 2.1.2 Boehringer Ingelheim Major Business
  • 2.1.3 Boehringer Ingelheim Pet Vaccine Product and Services
  • 2.1.4 Boehringer Ingelheim Pet Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
  • 2.1.5 Boehringer Ingelheim Recent Developments/Updates
• 2.2 Zoetis
  • 2.2.1 Zoetis Details
  • 2.2.2 Zoetis Major Business
  • 2.2.3 Zoetis Pet Vaccine Product and Services
  • 2.2.4 Zoetis Pet Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
  • 2.2.5 Zoetis Recent Developments/Updates
• 2.3 Elanco Animal Health
  • 2.3.1 Elanco Animal Health Details
  • 2.3.2 Elanco Animal Health Major Business
  • 2.3.3 Elanco Animal Health Pet Vaccine Product and Services
  • 2.3.4 Elanco Animal Health Pet Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
  • 2.3.5 Elanco Animal Health Recent Developments/Updates
• 2.4 Merck Animal Health
  • 2.4.1 Merck Animal Health Details
  • 2.4.2 Merck Animal Health Major Business
  • 2.4.3 Merck Animal Health Pet Vaccine Product and Services
  • 2.4.4 Merck Animal Health Pet Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
  • 2.4.5 Merck Animal Health Recent Developments/Updates
• 2.5 Virbac
  • 2.5.1 Virbac Details
  • 2.5.2 Virbac Major Business
  • 2.5.3 Virbac Pet Vaccine Product and Services
  • 2.5.4 Virbac Pet Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
  • 2.5.5 Virbac Recent Developments/Updates
• 2.6 Dechra Veterinary Products
  • 2.6.1 Dechra Veterinary Products Details
  • 2.6.2 Dechra Veterinary Products Major Business
  • 2.6.3 Dechra Veterinary Products Pet Vaccine Product and Services
  • 2.6.4 Dechra Veterinary Products Pet Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
  • 2.6.5 Dechra Veterinary Products Recent Developments/Updates
• 2.7 Ceva
  • 2.7.1 Ceva Details
  • 2.7.2 Ceva Major Business
  • 2.7.3 Ceva Pet Vaccine Product and Services
  • 2.7.4 Ceva Pet Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
  • 2.7.5 Ceva Recent Developments/Updates
• 2.8 Vetoquinol
  • 2.8.1 Vetoquinol Details
  • 2.8.2 Vetoquinol Major Business
  • 2.8.3 Vetoquinol Pet Vaccine Product and Services
  • 2.8.4 Vetoquinol Pet Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
  • 2.8.5 Vetoquinol Recent Developments/Updates
• 2.9 Meiji
  • 2.9.1 Meiji Details
  • 2.9.2 Meiji Major Business
  • 2.9.3 Meiji Pet Vaccine Product and Services
  • 2.9.4 Meiji Pet Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
  • 2.9.5 Meiji Recent Developments/Updates
• 2.10 Ouro Fino Saude
  • 2.10.1 Ouro Fino Saude Details
  • 2.10.2 Ouro Fino Saude Major Business
  • 2.10.3 Ouro Fino Saude Pet Vaccine Product and Services
  • 2.10.4 Ouro Fino Saude Pet Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
  • 2.10.5 Ouro Fino Saude Recent Developments/Updates
• 2.11 Animalcare Group
  • 2.11.1 Animalcare Group Details
  • 2.11.2 Animalcare Group Major Business
  • 2.11.3 Animalcare Group Pet Vaccine Product and Services
  • 2.11.4 Animalcare Group Pet Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
  • 2.11.5 Animalcare Group Recent Developments/Updates
• 2.12 Parnell
  • 2.12.1 Parnell Details
  • 2.12.2 Parnell Major Business
  • 2.12.3 Parnell Pet Vaccine Product and Services
  • 2.12.4 Parnell Pet Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
  • 2.12.5 Parnell Recent Developments/Updates
• 2.13 CAHIC
  • 2.13.1 CAHIC Details
  • 2.13.2 CAHIC Major Business
  • 2.13.3 CAHIC Pet Vaccine Product and Services
  • 2.13.4 CAHIC Pet Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
  • 2.13.5 CAHIC Recent Developments/Updates
• 2.14 Ringpu
  • 2.14.1 Ringpu Details
  • 2.14.2 Ringpu Major Business
  • 2.14.3 Ringpu Pet Vaccine Product and Services
  • 2.14.4 Ringpu Pet Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
  • 2.14.5 Ringpu Recent Developments/Updates
• 2.15 Jinyu Group
  • 2.15.1 Jinyu Group Details
  • 2.15.2 Jinyu Group Major Business
  • 2.15.3 Jinyu Group Pet Vaccine Product and Services
  • 2.15.4 Jinyu Group Pet Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
  • 2.15.5 Jinyu Group Recent Developments/Updates
• 2.16 Keqian Biology
  • 2.16.1 Keqian Biology Details
  • 2.16.2 Keqian Biology Major Business
  • 2.16.3 Keqian Biology Pet Vaccine Product and Services
  • 2.16.4 Keqian Biology Pet Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
  • 2.16.5 Keqian Biology Recent Developments/Updates
• 2.17 Kyoritsu Seiyaku
  • 2.17.1 Kyoritsu Seiyaku Details
  • 2.17.2 Kyoritsu Seiyaku Major Business
  • 2.17.3 Kyoritsu Seiyaku Pet Vaccine Product and Services
  • 2.17.4 Kyoritsu Seiyaku Pet Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
  • 2.17.5 Kyoritsu Seiyaku Recent Developments/Updates

3 Competitive Environment: Pet Vaccine by Manufacturer

• 3.1 Global Pet Vaccine Sales Quantity by Manufacturer (2020-2025)
• 3.2 Global Pet Vaccine Revenue by Manufacturer (2020-2025)
• 3.3 Global Pet Vaccine Average Price by Manufacturer (2020-2025)
• 3.4 Market Share Analysis (2024)
  • 3.4.1 Producer Shipments of Pet Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2024
  • 3.4.2 Top 3 Pet Vaccine Manufacturer Market Share in 2024
  • 3.4.3 Top 6 Pet Vaccine Manufacturer Market Share in 2024
• 3.5 Pet Vaccine Market: Overall Company Footprint Analysis
  • 3.5.1 Pet Vaccine Market: Region Footprint
  • 3.5.2 Pet Vaccine Market: Company Product Type Footprint
  • 3.5.3 Pet Vaccine Market: Company Product Application Footprint
• 3.6 New Market Entrants and Barriers to Market Entry
• 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

• 4.1 Global Pet Vaccine Market Size by Region
  • 4.1.1 Global Pet Vaccine Sales Quantity by Region (2020-2031)
  • 4.1.2 Global Pet Vaccine Consumption Value by Region (2020-2031)
  • 4.1.3 Global Pet Vaccine Average Price by Region (2020-2031)
• 4.2 North America Pet Vaccine Consumption Value (2020-2031)
• 4.3 Europe Pet Vaccine Consumption Value (2020-2031)
• 4.4 Asia-Pacific Pet Vaccine Consumption Value (2020-2031)
• 4.5 South America Pet Vaccine Consumption Value (2020-2031)
• 4.6 Middle East & Africa Pet Vaccine Consumption Value (2020-2031)

5 Market Segment by Type

• 5.1 Global Pet Vaccine Sales Quantity by Type (2020-2031)
• 5.2 Global Pet Vaccine Consumption Value by Type (2020-2031)
• 5.3 Global Pet Vaccine Average Price by Type (2020-2031)

6 Market Segment by Application

• 6.1 Global Pet Vaccine Sales Quantity by Application (2020-2031)
• 6.2 Global Pet Vaccine Consumption Value by Application (2020-2031)
• 6.3 Global Pet Vaccine Average Price by Application (2020-2031)

7 North America

• 7.1 North America Pet Vaccine Sales Quantity by Type (2020-2031)
• 7.2 North America Pet Vaccine Sales Quantity by Application (2020-2031)
• 7.3 North America Pet Vaccine Market Size by Country
  • 7.3.1 North America Pet Vaccine Sales Quantity by Country (2020-2031)
  • 7.3.2 North America Pet Vaccine Consumption Value by Country (2020-2031)
  • 7.3.3 United States Market Size and Forecast (2020-2031)
  • 7.3.4 Canada Market Size and Forecast (2020-2031)
  • 7.3.5 Mexico Market Size and Forecast (2020-2031)

8 Europe

• 8.1 Europe Pet Vaccine Sales Quantity by Type (2020-2031)
• 8.2 Europe Pet Vaccine Sales Quantity by Application (2020-2031)
• 8.3 Europe Pet Vaccine Market Size by Country
  • 8.3.1 Europe Pet Vaccine Sales Quantity by Country (2020-2031)
  • 8.3.2 Europe Pet Vaccine Consumption Value by Country (2020-2031)
  • 8.3.3 Germany Market Size and Forecast (2020-2031)
  • 8.3.4 France Market Size and Forecast (2020-2031)
  • 8.3.5 United Kingdom Market Size and Forecast (2020-2031)
  • 8.3.6 Russia Market Size and Forecast (2020-2031)
  • 8.3.7 Italy Market Size and Forecast (2020-2031)

9 Asia-Pacific

• 9.1 Asia-Pacific Pet Vaccine Sales Quantity by Type (2020-2031)
• 9.2 Asia-Pacific Pet Vaccine Sales Quantity by Application (2020-2031)
• 9.3 Asia-Pacific Pet Vaccine Market Size by Region
  • 9.3.1 Asia-Pacific Pet Vaccine Sales Quantity by Region (2020-2031)
  • 9.3.2 Asia-Pacific Pet Vaccine Consumption Value by Region (2020-2031)
  • 9.3.3 China Market Size and Forecast (2020-2031)
  • 9.3.4 Japan Market Size and Forecast (2020-2031)
  • 9.3.5 South Korea Market Size and Forecast (2020-2031)
  • 9.3.6 India Market Size and Forecast (2020-2031)
  • 9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
  • 9.3.8 Australia Market Size and Forecast (2020-2031)

10 South America

• 10.1 South America Pet Vaccine Sales Quantity by Type (2020-2031)
• 10.2 South America Pet Vaccine Sales Quantity by Application (2020-2031)
• 10.3 South America Pet Vaccine Market Size by Country
  • 10.3.1 South America Pet Vaccine Sales Quantity by Country (2020-2031)
  • 10.3.2 South America Pet Vaccine Consumption Value by Country (2020-2031)
  • 10.3.3 Brazil Market Size and Forecast (2020-2031)
  • 10.3.4 Argentina Market Size and Forecast (2020-2031)

11 Middle East & Africa

• 11.1 Middle East & Africa Pet Vaccine Sales Quantity by Type (2020-2031)
• 11.2 Middle East & Africa Pet Vaccine Sales Quantity by Application (2020-2031)
• 11.3 Middle East & Africa Pet Vaccine Market Size by Country
  • 11.3.1 Middle East & Africa Pet Vaccine Sales Quantity by Country (2020-2031)
  • 11.3.2 Middle East & Africa Pet Vaccine Consumption Value by Country (2020-2031)
  • 11.3.3 Turkey Market Size and Forecast (2020-2031)
  • 11.3.4 Egypt Market Size and Forecast (2020-2031)
  • 11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
  • 11.3.6 South Africa Market Size and Forecast (2020-2031)

12 Market Dynamics

• 12.1 Pet Vaccine Market Drivers
• 12.2 Pet Vaccine Market Restraints
• 12.3 Pet Vaccine Trends Analysis
• 12.4 Porters Five Forces Analysis
  • 12.4.1 Threat of New Entrants
  • 12.4.2 Bargaining Power of Suppliers
  • 12.4.3 Bargaining Power of Buyers
  • 12.4.4 Threat of Substitutes
  • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

• 13.1 Raw Material of Pet Vaccine and Key Manufacturers
• 13.2 Manufacturing Costs Percentage of Pet Vaccine
• 13.3 Pet Vaccine Production Process
• 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

• 14.1 Sales Channel
  • 14.1.1 Direct to End-User
  • 14.1.2 Distributors
• 14.2 Pet Vaccine Typical Distributors
• 14.3 Pet Vaccine Typical Customers

15 Research Findings and Conclusion

16 Appendix

• 16.1 Methodology
• 16.2 Research Process and Data Source

According to our (Global Info Research) latest study, the global Pet Vaccine market size was valued at US$ 3947 million in 2024 and is forecast to a readjusted size of USD 6341 million by 2031 with a CAGR of 6.9% during review period.
Pet vaccines are biological preparations designed to stimulate an immune response in pets, protecting them from infectious diseases caused by viruses, bacteria, and other pathogens. These vaccines help prevent severe illnesses such as rabies, distemper, parvovirus, and feline leukemia, reducing mortality rates and improving the overall health of companion animals. Vaccination is a crucial aspect of preventive veterinary care and is commonly administered to dogs, cats, and other domesticated animals based on specific vaccination schedules.
With advancements in veterinary medicine, modern pet vaccines are becoming more effective, safer, and tailored to specific breeds and regional disease risks. Innovations such as recombinant vaccines and mRNA-based vaccines are enhancing immune responses with fewer side effects. As pet ownership rises globally and awareness of animal health increases, the demand for high-quality pet vaccines continues to grow, supporting both public health and animal welfare.
Market Drivers:
The pet vaccine market is primarily driven by the increasing pet ownership worldwide and a growing awareness of animal health and preventive care. As more people adopt pets, the demand for vaccines to protect them from infectious diseases rises, especially with the expansion of the pet care industry. Moreover, advancements in veterinary vaccines, including more effective and safer vaccines, are improving vaccination outcomes and encouraging wider use. Public health initiatives and regulations, such as rabies vaccination requirements, also play a role in fueling market growth. Additionally, rising disposable incomes, particularly in emerging markets, are enabling pet owners to spend more on veterinary care, including vaccinations.
Market Challenges:
One of the major challenges facing the pet vaccine market is the high cost of some vaccines, which can be a barrier to regular vaccination, especially for pet owners in lower-income regions. Furthermore, the increasing complexity of vaccine schedules and the need for specialized veterinary care may slow down adoption rates in some areas. In addition, the emergence of counterfeit or low-quality vaccines poses a significant threat to market growth and animal health. Regulatory barriers and inconsistencies across different regions can also hinder the efficient distribution and accessibility of vaccines, especially in emerging markets with less-developed veterinary infrastructure.
This report is a detailed and comprehensive analysis for global Pet Vaccine market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Pet Vaccine market size and forecasts, in consumption value ($ Million), sales quantity (K Doses), and average selling prices (USD/Dose), 2020-2031
Global Pet Vaccine market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Doses), and average selling prices (USD/Dose), 2020-2031
Global Pet Vaccine market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Doses), and average selling prices (USD/Dose), 2020-2031
Global Pet Vaccine market shares of main players, shipments in revenue ($ Million), sales quantity (K Doses), and ASP (USD/Dose), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Pet Vaccine
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Pet Vaccine market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Boehringer Ingelheim, Zoetis, Elanco Animal Health, Merck Animal Health, Virbac, Dechra Veterinary Products, Ceva, Vetoquinol, Meiji, Ouro Fino Saude, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Pet Vaccine market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Nasal Administration
Injection
Other
Market segment by Application
Cat
Dog
Other
Major players covered
Boehringer Ingelheim
Zoetis
Elanco Animal Health
Merck Animal Health
Virbac
Dechra Veterinary Products
Ceva
Vetoquinol
Meiji
Ouro Fino Saude
Animalcare Group
Parnell
CAHIC
Ringpu
Jinyu Group
Keqian Biology
Kyoritsu Seiyaku
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Pet Vaccine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Pet Vaccine, with price, sales quantity, revenue, and global market share of Pet Vaccine from 2020 to 2025.
Chapter 3, the Pet Vaccine competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Pet Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Pet Vaccine market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Pet Vaccine.
Chapter 14 and 15, to describe Pet Vaccine sales channel, distributors, customers, research findings and conclusion.